ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ·Healthcare·Biotechnology
$27.01
-1.60%
Mkt Cap $4.58B
Analyst Ratings
Buy
14
Hold
2
Sell
0
Price Target (63 analysts)
$34.33
Range $29.00 – $37.00
Implied Upside
+27.1%
Consensus $34.33 vs current $27.01
NASDAQ·Healthcare·Biotechnology
$27.01
-1.60%
Mkt Cap $4.58B
Buy
14
Hold
2
Sell
0
Price Target (63 analysts)
$34.33
Range $29.00 – $37.00
+27.1%
Consensus $34.33 vs current $27.01